StockData
Clearmind Medicine Inc. logo

Clearmind Medicine Inc. (CMND) stock

CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$3.06−0.39 (-11.16%)

Close on Nov 18, 2026Market cap $484.50KP/E –Yield –

Clearmind Medicine shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Clearmind Medicine's shares outstanding was 2M at Jul 31, 2026. For fiscal 2025 it was 0M, up 64.0% from the year before. The highest annual figure on record is 0M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Oct 31, 20250M+64.0%
FY2024Oct 31, 20240M+1431.1%
FY2023Oct 31, 20230M+367.4%
FY2022Oct 31, 20220M+40.1%
FY2021Oct 31, 20210M+70.6%
FY2020Oct 31, 20200M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jul 31, 20262M+11549.9%
Q2 FY2026CQ1 2026Apr 30, 20260M+2298.6%
Q1 FY2026CQ4 2025Jan 31, 20261M+935.6%
Q4 FY2025CQ3 2025Oct 31, 20250M+34.1%
Q3 FY2025CQ2 2025Jul 31, 20250M-84.7%
Q2 FY2025CQ1 2025Apr 30, 20250M-84.5%
Q1 FY2025CQ4 2024Jan 31, 20250M+195.8%
Q4 FY2024CQ3 2024Oct 31, 20240M+998.5%
Q3 FY2024CQ2 2024Jul 31, 20240M+1406.6%
Q2 FY2024CQ1 2024Apr 30, 20240M+2504.3%
Q1 FY2024CQ4 2023Jan 31, 20240M+1881.0%
Q4 FY2023CQ3 2023Oct 31, 20230M+751.1%
Q3 FY2023CQ2 2023Jul 31, 20230M+466.3%
Q2 FY2023CQ1 2023Apr 30, 20230M–
Q1 FY2023CQ4 2022Jan 31, 20230M–
Q2 FY2022CQ1 2022Apr 30, 20220M–
Q1 FY2022CQ4 2021Jan 31, 20220M–

More Clearmind Medicine figures

See a number that looks wrong?